Sanofi ADS (SNY)

American Depository Receipt

Sell: $47.26|Buy: $47.43|Change: 0.38 (-0.79%)

Open

$47.92

Previous close

$47.82

Trade high

$48.00

Volume

2,309,472

Year high

$60.115

Year low

$44.6168

Dividend yield

4.59%

Market capitalisation

$115.23 bn

P/E ratio

15.55

ISIN

US80105N1054

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Dividends

	Previous	Latest
Record date	10/05/2024	09/05/2025
Ex-dividend date	09/05/2024	09/05/2025
Payment date	06/06/2024	12/06/2025
Amount	$2.03691	$2.19533

Performance 16/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Sanofi ADS	- 0.79
More...

Company profile

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.